170 related articles for article (PubMed ID: 2503225)
1. Depression of maximum rate of depolarization of guinea-pig ventricular action potentials by metabolites of encainide.
Hemsworth PD; Campbell TJ
Br J Pharmacol; 1989 Jun; 97(2):619-25. PubMed ID: 2503225
[TBL] [Abstract][Full Text] [Related]
2. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide.
Campbell TJ
J Cardiovasc Pharmacol; 1983; 5(2):291-6. PubMed ID: 6188905
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart.
Carmeliet E
Eur J Pharmacol; 1980 Feb; 61(3):247-62. PubMed ID: 6767615
[TBL] [Abstract][Full Text] [Related]
4. Comparative antiarrhythmic actions of encainide and its major metabolites.
Gomoll AW; Byrne JE; Mayol RF
Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):277-97. PubMed ID: 3092755
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological effects of encainide (MJ9067) on canine subendocardial Purkinje fibers surviving infarction.
King BW; Man RY
J Cardiovasc Pharmacol; 1984; 6(4):547-54. PubMed ID: 6206306
[TBL] [Abstract][Full Text] [Related]
6. Selective depression of maximum rate of depolarization of guinea-pig ventricular action potentials by amiodarone and lignocaine in simulated ischaemia: comparison with encainide.
Campbell TJ; Hemsworth PD
Clin Exp Pharmacol Physiol; 1990 Feb; 17(2):135-45. PubMed ID: 2158404
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological effects of encainide and its metabolites in normal canine Purkinje fibers and Purkinje fibers surviving infarction.
Kinnaird AA; Man RY
Can J Physiol Pharmacol; 1989 Jul; 67(7):751-6. PubMed ID: 2504469
[TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo electrophysiologic effects of encainide.
Libersa C; Caron J; Rouet R
Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():567-72. PubMed ID: 2125834
[TBL] [Abstract][Full Text] [Related]
9. Voltage- and time-dependent depression of maximum rate of depolarization of guinea-pig ventricular action potentials by two steroidal antiarrhythmic drugs, CCI 22277 and ORG 6001.
Campbell TJ
Br J Pharmacol; 1982 Nov; 77(3):541-8. PubMed ID: 7139201
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.
Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
Circulation; 1988 Feb; 77(2):380-91. PubMed ID: 3123092
[TBL] [Abstract][Full Text] [Related]
11. Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide.
Campbell TJ; Vaughan Williams EM
Cardiovasc Res; 1983 May; 17(5):251-8. PubMed ID: 6883400
[TBL] [Abstract][Full Text] [Related]
12. Effects of hyperkalemia, acidosis, and hypoxia on the depression of maximum rate of depolarization by class I antiarrhythmic drugs in guinea pig myocardium: differential actions of class Ib and Ic agents.
Campbell TJ; Wyse KR; Hemsworth PD
J Cardiovasc Pharmacol; 1991 Jul; 18(1):51-9. PubMed ID: 1719292
[TBL] [Abstract][Full Text] [Related]
13. Use-dependent effects of pirmenol on Vmax and conduction in guinea-pig ventricular myocardium.
Hasegawa J; Hirai S; Noguchi N; Hisatome I; Kotake H; Mashiba H
Br J Pharmacol; 1990 Apr; 99(4):815-9. PubMed ID: 2361175
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic effects of McN-4130, a new antiarrhythmic compound, on isolated cardiac tissue.
Damiano BP; Brannan MD
J Cardiovasc Pharmacol; 1987 Nov; 10(5):498-508. PubMed ID: 2447397
[TBL] [Abstract][Full Text] [Related]
15. Temperature and voltage dependence of sodium channel blocking and unblocking by O-demethyl encainide in isolated guinea pig myocytes.
Johns JA; Anno T; Bennett PB; Snyders DJ; Hondeghem LM
J Cardiovasc Pharmacol; 1989 Jun; 13(6):826-35. PubMed ID: 2484076
[TBL] [Abstract][Full Text] [Related]
16. Effect of encainide and its two major metabolites on cardiac conduction.
Dresel PE
J Pharmacol Exp Ther; 1984 Jan; 228(1):180-6. PubMed ID: 6420542
[TBL] [Abstract][Full Text] [Related]
17. Developmental electrophysiology of encainide and its major metabolites on the Purkinje fiber action potential.
Case CL; Hewett KW; Gillette PC
Biol Neonate; 1994; 66(6):330-8. PubMed ID: 7727615
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Roden DM; Lee JT; Woosley RL; Echt DS
Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
[TBL] [Abstract][Full Text] [Related]
19. Myocardial uptake of encainide and its two major metabolites, O-demethyl encainide and 3-methoxy-O-demethyl encainide, in the dog.
Latini R; Gillis AM; Kates RE
J Cardiovasc Pharmacol; 1984; 6(4):663-7. PubMed ID: 6206322
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological effects of dridocainide on isolated canine, guinea-pig and human cardiac tissues.
Pankucsi C; Hegedüs M; Kovács A; Szénási G; Szemerédi K; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):520-8. PubMed ID: 8751081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
